[ad_1] Merck & Co.has struck a deal to buy clinical-stage immunotherapy company Harpoon Therapeutics for about $680 million. Merck on Monday said it will pay $23 a share in cash…
Tag: Therapeutics
Investors in Invex Therapeutics (ASX:IXC) have unfortunately lost 56% over the last three years
[ad_1] The truth is that if you invest for long enough, you’re going to end up with some losing stocks. But the last three years have been particularly tough on…
Bristol Myers Squibb Acquires Karuna Therapeutics for $14 Billion, Boosting Neuroscience Portfolio
[ad_1] NEW YORK (AP) — Drugmaker Bristol Myers Squibb is acquiring Karuna Therapeutics, a biopharmaceutical company that has developed a new antipsychotic, in a $14 billion deal. Bristol Myers Squibb…
Karuna Therapeutics surges 47% after Bristol Myers Squibb announces $14 billion deal
[ad_1] Bristol Myers Squibb on Friday announced it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash, or $330 per share. Karuna’s stock popped more than 47%…
ImmunoScape Partners with Singapore’s Experimental Drug Development Centre to Develop Novel T Cell Receptor-Based Therapeutics
[ad_1] The collaboration seeks to produce novel off-the-shelf TCR-based bispecific molecules designed to overcome current limitations in cell therapy approaches against solid tumors SAN DIEGO & SINGAPORE, December 21, 2023–(BUSINESS…
AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion
[ad_1] A sign stands outside a Abbvie facility in Cambridge, Massachusetts, May 20, 2021. Brian Snyder | Reuters AbbVie on Wednesday said it will acquire neuroscience drugmaker Cerevel Therapeutics for…
Altamira Therapeutics to Host Investor & Business Update Call on December 11th
[ad_1] Altamira Therapeutics Ltd HAMILTON, BERMUDA , Dec. 05, 2023 (GLOBE NEWSWIRE) — HAMILTON, BERMUDA–December 5, 2023–Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (Nasdaq: CYTO), a company dedicated to developing…
CytoMed Therapeutics Signs HOA and MOU to Advance Research on Allogeneic Gamma Delta T Cell Technology
[ad_1] SINGAPORE, Dec. 5, 2023 /PRNewswire/ — CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based biopharmaceutical company focused on harnessing its proprietary technologies to develop novel donor-derived cell-based…
Abbisko Therapeutics Announced the Entry into a Licensing Agreement for Pimicotinib (ABSK021) with Merck
[ad_1] SHANGHAI, Dec. 4, 2023 /PRNewswire/ — On 4 Dec. 2023, Abbisko Therapeutics announced that it has entered into a licensing agreement with Merck, a leading science and technology company…
Roche Strikes Deal to Buy Drug Developer Carmot Therapeutics for $2.7 Bln
[ad_1] Roche aims to buy Carmot Therapeutics, a California-based pharmaceutical firm developing drugs to treat obesity and diabetes. The Swiss pharmaceutical company said it has entered an agreement to acquire…